https://wiki.tiffa.net/w/index.php?action=history&feed=atom&title=Translations%3ADulaglutide%2F20%2FenTranslations:Dulaglutide/20/en - Revision history2026-08-30T16:11:46ZRevision history for this page on the wikiMediaWiki 1.43.0https://wiki.tiffa.net/w/index.php?title=Translations:Dulaglutide/20/en&diff=113620&oldid=prevFuzzyBot: Importing a new version from external source2024-02-12T01:29:32Z<p>Importing a new version from external source</p>
<p><b>New page</b></p><div>== Further reading ==<br />
* {{cite journal | vauthors = Scott LJ | title = Dulaglutide: A Review in Type 2 Diabetes | journal = Drugs | volume = 80 | issue = 2 | pages = 197–208 | date = February 2020 | pmid = 32002850 | doi = 10.1007/s40265-020-01260-9 | s2cid = 210954338 }}<br />
* {{cite journal | vauthors = Edwards KL, Minze MG | title = Dulaglutide: an evidence-based review of its potential in the treatment of type 2 diabetes | journal = Core Evidence | volume = 10 | pages = 11–21 | date = 2015 | pmid = 25657615 | pmc = 4295897 | doi = 10.2147/CE.S55944 | doi-access = free }}<br />
* {{cite journal | vauthors = Romera I, Cebrián-Cuenca A, Álvarez-Guisasola F, Gomez-Peralta F, Reviriego J | title = A Review of Practical Issues on the Use of Glucagon-Like Peptide-1 Receptor Agonists for the Management of Type 2 Diabetes | journal = Diabetes Therapy | volume = 10 | issue = 1 | pages = 5–19 | date = February 2019 | pmid = 30506340 | pmc = 6349277 | doi = 10.1007/s13300-018-0535-9 }}</div>FuzzyBot